New infection tests for orthopedic surgery can now get to market faster
What happened
US health regulators just made it easier to approve new tests for bone and joint infections. This means doctors will get more options to quickly identify bacteria and antibiotic resistance in patients.
Why it matters
For years, getting new diagnostic tests for complex infections approved was a slow process. This change means companies can bring new tests to market faster, especially for orthopedic infections where quick diagnosis is critical. It should lead to more precise treatments and fewer unnecessary surgeries or antibiotic use.
The signal
Watch for an increase in new diagnostic tests for orthopedic infections appearing on the market in the next 12-24 months.